The translational relevance of quantitative assessment of CD64 levels on neutrophils in clinical settings is supported by its use in other conditions, including the discrimination between sepsis and non-septic systemic inflammatory response syndrome (76, 77). The gene discussed is FCGR1A; the disease is systemic inflammatory response syndrome.